Domainex (AgeTech UK) Biomed
Drug discovery services. Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research.
Investment Stage:
N/A
Funding Status:
N/A
Headquarters:
United Kingdom
Industry:
UK AgeTech 2020
Number Of Exists:
N/A
Investor Type:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Founded Date:
N/A